Author name: Modulight Content

Modulight wants to share high-quality scientific publications, white papers, application notes, and other articles. The articles shared are courtesy of the authoring researchers and groups and we're thankful for giving us the permission to honor their work this way. If you have something to share please drop us a line (see the contact form at Contact Us section).

Modulight Spotlights: LASER-SHARP RESEARCH – May 2025

Cheng-Yu Lai et al. at Florida International University explores a solution for antibiotic-free wound healing. A photothermally controllable hydrogel was illuminated by NIR light from ML6600 laser, causing complete eradication of bacteria.

Modulight Spotlights: LASER-SHARP RESEARCH – May 2025 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – April 2025

Gokalp et al. from University of Massachusetts and Tufts University constructed an innovative liquid metal nanoparticle platform, which has tumor cell targeting and enhanced encapsulation of verteporfin. Charactierization in vitro with the help of ML6600 laser showed effective in vitro phototoxicity.

Modulight Spotlights: LASER-SHARP RESEARCH – April 2025 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – March 2025

Coleman et al. / MSKCC developed a vascular-targeted therapy for bladder cancer. Padeliporfin is illuminated with the Modulight’s ML7710 laser, resulting in selective ablation of bladder tumors, without harming the healthy bladder tissue.

Modulight Spotlights: LASER-SHARP RESEARCH – March 2025 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – February 2025

A. Lepland and the teams at University of Tartu, Estonia and Veneto Institute of Oncology, Italy, developed a new immunotherapy for triple negative breast cancer, using Modulight ML6000-series laser. Tumor growth slowed down and the cancer’s spreading to the lungs was suppressed.

Modulight Spotlights: LASER-SHARP RESEARCH – February 2025 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – January 2025

Kobayashi et al. at NIH developed a therapy which results in tumor cell membrane destruction and immunogenic cell death. When activated with the ML7710 laser, there was proven efficacy against various cancer cell types including pancreatic, oral, breast, and ovarian cancer.

Modulight Spotlights: LASER-SHARP RESEARCH – January 2025 Read More »

Introducing Modulight’s Versatile DBR Laser platform

Introducing Modulight’s Versatile DBR Laser platform Modulight announces the launch of its latest Distributed Bragg Reflector (DBR) lasers, offering a configurable wavelength range from 630 nm to 1100 nm. These advanced lasers are designed to meet the high demands in quantum systems, quantum sensing, Raman spectroscopy, and metrology.  Key wavelengths of Modulight DBR laser platform

Introducing Modulight’s Versatile DBR Laser platform Read More »

ML6600 Expands with VECSEL-Based Variants for Flow Cytometry

Advancing Flow Cytometry Precision with VECSEL-Based Flow Cytometry Lasers Modulight expands its ML6600 product family with new high-performance flow cytometry lasers designed to meet the rigorous demands of cell analysis and sorting. Featuring Modulight’s OP-VECSEL (Optically-Pumped Vertical-External-Cavity Surface-Emitting Laser) core technology, these latest ML6600 variants offer unparalleled stability, beam quality, and efficiency for biomedical research

ML6600 Expands with VECSEL-Based Variants for Flow Cytometry Read More »

Modulight Introduces High-Performance Tapered Amplifiers and DBR MOPA Devices

Modulight Introduces High-Performance Tapered Amplifiers and DBR MOPA Devices Modulight is broadening its advanced laser solutions portfolio with a range of tapered amplifier products and monolithic DBR MOPA devices, delivering high output power with excellent beam quality.  Designed for Master Oscillator Power Amplifier (MOPA) configurations, Modulight’s tapered amplifiers ensure efficient amplification while preserving the seed

Modulight Introduces High-Performance Tapered Amplifiers and DBR MOPA Devices Read More »

Scroll to Top